# Hagop M. Kantarjian, M.D. – FDA Inspection, May 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/08493f8b-285f-4255-ba4d-0475c6e5c680
Source feed: FDA_Inspections

> FDA inspection 1029979 of Hagop M. Kantarjian, M.D., May 05, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 50 and 312. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029979
- Company Name: Hagop M. Kantarjian, M.D.
- Inspection Date: 2017-05-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1048237 - 2018-03-16
- FDA Inspection 898289 - 2014-09-17
- FDA Inspection 896497 - 2014-09-11
- [FDA Inspection 746460 - 2011-09-16](https://www.keypedia.com/records/fda_inspections/hagop-m-kantarjian-md/28ae3d8d-9664-418a-b943-68907bf72f9e)

## Related Officers

- [Alanna L. Mussawwir Bias](https://www.keypedia.com/people/alanna-l-mussawwir-bias/514fda77-1849-4faf-af07-e62d7c6af58e)

Company: https://www.keypedia.com/companies/hagop-m-kantarjian-md/57a20198-e024-409a-b67e-d0b49222c3a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
